Biocon Limited (BIOCON.BO)
INR 348.0
(0.01%)
INR 348.0
(0.01%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 129.32 Billion INR | -16.56% |
| 2022 | 154.99 Billion INR | 267.29% |
| 2021 | 42.2 Billion INR | 37.2% |
| 2020 | 30.75 Billion INR | 135.63% |
| 2019 | 13.05 Billion INR | -15.28% |
| 2018 | 15.4 Billion INR | -13.92% |
| 2017 | 17.89 Billion INR | -15.1% |
| 2016 | 21.08 Billion INR | 1.73% |
| 2015 | 20.72 Billion INR | 170.16% |
| 2014 | 7.67 Billion INR | 30.73% |
| 2013 | 5.86 Billion INR | 345.9% |
| 2012 | 1.31 Billion INR | 439.34% |
| 2011 | 244 Million INR | 229.73% |
| 2010 | 74 Million INR | -98.56% |
| 2009 | 5.13 Billion INR | -1.97% |
| 2008 | 5.23 Billion INR | 105.41% |
| 2007 | 2.55 Billion INR | 36.56% |
| 2006 | 1.86 Billion INR | 77.8% |
| 2005 | 1.05 Billion INR | 37.6% |
| 2004 | 763.41 Million INR | 18.01% |
| 2003 | 646.91 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 119.81 Billion INR | -3.79% |
| 2024 Q1 | 124.54 Billion INR | -3.7% |
| 2023 Q2 | 153.66 Billion INR | -2.99% |
| 2023 Q1 | 158.39 Billion INR | 2.19% |
| 2023 FY | 129.32 Billion INR | -16.56% |
| 2023 Q4 | 129.32 Billion INR | -1.89% |
| 2023 Q3 | 131.81 Billion INR | -14.22% |
| 2022 Q3 | 144.62 Billion INR | 212.26% |
| 2022 Q2 | 46.31 Billion INR | 6.59% |
| 2022 FY | 154.99 Billion INR | 267.29% |
| 2022 Q1 | 43.45 Billion INR | 2.96% |
| 2022 Q4 | 154.99 Billion INR | 7.17% |
| 2021 Q1 | 29.01 Billion INR | -5.68% |
| 2021 FY | 42.2 Billion INR | 37.2% |
| 2021 Q2 | 31.3 Billion INR | 7.91% |
| 2021 Q3 | 31.12 Billion INR | -0.59% |
| 2021 Q4 | 42.2 Billion INR | 35.6% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 20.66 Billion INR | 0.0% |
| 2020 Q4 | 30.75 Billion INR | 0.0% |
| 2020 FY | 30.75 Billion INR | 135.63% |
| 2019 FY | 13.05 Billion INR | -15.28% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 17.68 Billion INR | 0.0% |
| 2019 Q4 | 13.05 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 15.4 Billion INR | -11.45% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 18.46 Billion INR | 0.0% |
| 2018 Q3 | 17.4 Billion INR | -5.76% |
| 2018 FY | 15.4 Billion INR | -13.92% |
| 2017 Q1 | 20.7 Billion INR | -1.77% |
| 2017 Q4 | 17.89 Billion INR | -6.53% |
| 2017 Q3 | 19.14 Billion INR | -6.82% |
| 2017 Q2 | 20.55 Billion INR | -0.76% |
| 2017 FY | 17.89 Billion INR | -15.1% |
| 2016 Q2 | 21.36 Billion INR | 0.0% |
| 2016 FY | 21.08 Billion INR | 1.73% |
| 2016 Q3 | 22.3 Billion INR | 4.4% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 21.08 Billion INR | -5.46% |
| 2015 Q1 | 7.61 Billion INR | -0.8% |
| 2015 Q3 | 9.43 Billion INR | 7.38% |
| 2015 Q4 | 20.72 Billion INR | 119.77% |
| 2015 FY | 20.72 Billion INR | 170.16% |
| 2015 Q2 | 8.78 Billion INR | 15.4% |
| 2014 Q3 | 7.97 Billion INR | 1.78% |
| 2014 FY | 7.67 Billion INR | 30.73% |
| 2014 Q2 | 7.83 Billion INR | 11.23% |
| 2014 Q4 | 7.67 Billion INR | -3.75% |
| 2014 Q1 | 7.04 Billion INR | 19.97% |
| 2013 Q1 | 3.02 Billion INR | 129.48% |
| 2013 Q2 | 3.35 Billion INR | 11.05% |
| 2013 FY | 5.86 Billion INR | 345.9% |
| 2013 Q3 | 4.75 Billion INR | 41.63% |
| 2013 Q4 | 5.86 Billion INR | 23.54% |
| 2012 FY | 1.31 Billion INR | 439.34% |
| 2012 Q3 | 1.57 Billion INR | 0.0% |
| 2012 Q4 | 1.31 Billion INR | -16.18% |
| 2011 FY | 244 Million INR | 229.73% |
| 2011 Q4 | 244 Million INR | 0.0% |
| 2010 FY | 74 Million INR | -98.56% |
| 2009 FY | 5.13 Billion INR | -1.97% |
| 2008 FY | 5.23 Billion INR | 105.41% |
| 2007 FY | 2.55 Billion INR | 36.56% |
| 2006 FY | 1.86 Billion INR | 77.8% |
| 2005 FY | 1.05 Billion INR | 37.6% |
| 2004 FY | 763.41 Million INR | 18.01% |
| 2003 FY | 646.91 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | -9433.716% |
| Blue Jet Healthcare Limited | 3.79 Million INR | -3412142.744% |
| Concord Biotech Limited | 18.87 Million INR | -685241.812% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | -5165.421% |
| FERMENTA BIOTECH LIMITED | 425.36 Million INR | -30303.423% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 429.06 Million INR | -30040.747% |
| Panacea Biotec Limited | 209.9 Million INR | -61512.196% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | 5059.00 INR | -2556315377.367% |
| SMS Lifesciences India Limited | 331.45 Million INR | -38917.65% |
| Supriya Lifescience Limited | 50.2 Million INR | -257517.53% |
| Syngene International Limited | 1 Billion INR | -12832.4% |
| TAKE Solutions Limited | 7.5 Million INR | -1724220.0% |
| Titan Biotech Limited | 4.53 Million INR | -2852845.069% |
| Transgene Biotek Limited | 50.79 Million INR | -254499.862% |
| Vanta Bioscience Limited | 488.01 Million INR | -26400.059% |